Rationale and design of the EMBRACE STEMI study: a phase 2a, randomized, double-blind, placebo-controlled trial to evaluate the safety, tolerability and efficacy of intravenous Bendavia on reperfusion injury in patients treated with standard therapy (Q86503085)
Jump to navigation
Jump to search
scientific article published on 15 February 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Rationale and design of the EMBRACE STEMI study: a phase 2a, randomized, double-blind, placebo-controlled trial to evaluate the safety, tolerability and efficacy of intravenous Bendavia on reperfusion injury in patients treated with standard therapy |
scientific article published on 15 February 2013 |
Statements
Rationale and design of the EMBRACE STEMI study: a phase 2a, randomized, double-blind, placebo-controlled trial to evaluate the safety, tolerability and efficacy of intravenous Bendavia on reperfusion injury in patients treated with standard therapy including primary percutaneous coronary intervention and stenting for ST-segment elevation myocardial infarction (English)
Michal Tendera
Christoph Bode
Robert A Kloner
Jacek Godlewski
Anjan K Chakrabarti
Kristin Feeney
Cassandra Abueg
David A Brown
Ewa Czyz
Andras Janosi
Bela Merkely
C Michael Gibson
15 February 2013